ArticleFrontiers in artificial intelligence2025
Deep learning analysis of exercise stress electrocardiography for identification of significant coronary artery disease.
Article in Frontiers in artificial intelligence, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Development and evaluation of an artificial intelligence-based electrocardiogram prediction model for emergency chest pain patients.Frontiers in medicine · 2026Article
- The Role of Artificial Intelligence in Exercise-Based Cardiovascular Health Interventions: A Scoping Review.Journal of functional morphology and kinesiology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The diagnostic power of exercise stress electrocardiography (ExECG) remains limited. We aimed to construct an artificial intelligence (AI)-based method to enhance ExECG performance to identify patients with significant coronary artery disease (CAD). Methods: We retrospectively collected 818 patients who underwent both ExECG and coronary angiography (CAG) within 6 months. The mean age was 57.0 ± 10.1 years, and 614 (75%) were male patients. Significant coronary artery disease was seen in 369 (43.8%) CAG reports. We also included 197 individuals with normal ExECG and low risk of CAD. A convolutional recurrent neural network algorithm, integrating electrocardiographic (ECG) signals and features from ExECG reports, was developed to predict the risk of significant CAD. We also investigated the optimal number of inputted ECG signal slices and features and the weighting of features for model performance. Results: Using the data of patients undergoing CAG for training and test sets, our algorithm had an area under the curve, sensitivity, and specificity of 0.74, 0.86, and 0.47, respectively, which increased to 0.83, 0.89, and 0.60, respectively, after enrolling 197 subjects with low risk of CAD. Three ECG signal slices and 12 features yielded optimal performance metrics. The principal predictive feature variables were sex, maximum heart rate, and ST/HR index. Our model generated results within one minute after completing ExECG. Conclusion: The multimodal AI algorithm, leveraging deep learning techniques, efficiently and accurately identifies patients with significant CAD using ExECG data, aiding clinical screening in both symptomatic and asymptomatic patients. Nevertheless, the specificity remains moderate (0.60), suggesting a potential for false positives and highlighting the need for further investigation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.